[QT Interval in Patients With COVID-19].
Kardiologiia
; 60(7): 11-14, 2020 Aug 11.
Article
in Russian
| MEDLINE | ID: covidwho-994754
ABSTRACT
Since the first case recorded in the end of 2019, the virus SARS-CоV-2 and the related lung disease COVID-19 have spread over the world and became a threat for public health. The drugs used for treatment of this disease (azithromycin and hydroxychloroquine) can prolong the QT interval on the electrocardiogram to increase the risk of pirouette tachycardia and sudden cardiac death. This article presents a review of potential risks related with the drug treatment of COVID-19 and provides recommendations for management of patients during the pandemic.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Long QT Syndrome
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
Russian
Journal:
Kardiologiia
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS